Pediatric SARS-CoV-2 long term outcomes study (PECOS): cross sectional analysis at baseline

Gina A Montealegre Sanchez1, Lauren E Arrigoni2,3, Alexandra B Yonts3,4,5

  • 1Division of Clinical Research (DCR), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA. montealegrega@nih.gov.

Pediatric Research
|December 18, 2024
PubMed

Insights

Children infected with SARS-CoV-2 reported more symptoms and worse quality of life compared to uninfected children. This ongoing study, Pediatric COVID-19 Conquer Study (PECOS), will track long-term effects of COVID-19 in pediatric populations.

Area of Science:

  • Pediatric infectious diseases
  • Longitudinal cohort studies
  • COVID-19 outcomes

Background:

  • The Pediatric COVID-19 Conquer Study (PECOS) investigates long-term outcomes of SARS-CoV-2 infection in children.
  • Characterizing post-COVID-19 conditions in pediatric populations is crucial for understanding disease impact.

Purpose of the Study:

  • To characterize long-term outcomes following pediatric SARS-CoV-2 infection.
  • To compare symptoms, functional status, and quality of life between infected and uninfected children.

Main Methods:

  • Cross-sectional analysis of infected and uninfected pediatric cohorts (0-21 years) at baseline.
  • Data collection included demographics, medical history, symptoms, physical exams, cardiopulmonary evaluations, and validated psychological/developmental surveys.
  • Primary outcomes involved comparing cohort abnormalities across all collected measures.

Main Results:

  • Infected participants (n=541) reported more constitutional, HEENT, respiratory, and gastrointestinal symptoms compared to uninfected controls (n=113).
  • Infected children experienced worse Patient Reported Outcomes in domains including Pain, Fatigue, Global Health, Physical and Cognitive functioning, Mobility, and Sleep disturbances.
  • Cardiopulmonary findings were similar between infected and uninfected cohorts at baseline.

Conclusions:

  • Pediatric SARS-CoV-2 infection is associated with increased symptom reporting and diminished quality of life.
  • Longitudinal data from the PECOS study will enhance understanding of the long-term effects of COVID-19 in children, aiding in the identification of sequelae and contributing factors.
Abstract

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...